ARK Genomic Revolution
Large biotech companies
Details
ETF description
The ARK Genomic Revolution is an actively managed ETF that seeks long‑term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.
Issuer details
ARK Invest is an ETF provider specialising in thematic ETFs covering future‑oriented topics, disruptive technologies and megatrends. ARK Invest was founded in the USA in 2014 by economist and now world‑renowned investor Cathie Wood. Since 2016, ARK Invest is also active in the Asia‑Pacific region through a joint venture with the Japanese company Nikko Asset Management. In 2023, the company entered the European market with the acquisition of the European ETF provider Rize ETF.
Index details
This is an actively managed ETF and it does not follow any benchmark.
This ETF is in collections:
Key information
ETF Breakdown
Please try a different search.
Why InvestEngine
Unbeatable value
From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it
Choice of 700+ ETFs
Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
Browse investments
Actionable insights
Know exactly which companies, sectors and regions are in your portfolio.
Powerful automation
Grow your wealth the easy way with automated investing features
Easy diversification
Fractional investing lets you put as little as £1 in any ETF.
DIY or Managed
Build and manage your own portfolio or leave it to us.
